ClearPoint Neuro, Inc. (CLPT )

Currency in USD Disclaimer
$11.89 -$0.46 (-3.72%)
Closed 09/06/2024
$11.35
$12.57
$4.05
$13.47

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

  • Symbol CLPT
  • Company ClearPoint Neuro, Inc.
  • Price $11.89
  • Changes Percentage -3.72
  • Change -0.46
  • Day Low $11.35
  • Day High $12.57
  • Year High $13.47
  • Year Low $4.05
  • Market Cap $328,112,873
  • Price Avg 50 EMA (D) $8.57
  • Price Avg 200 EMA (D) $6.92
  • Exchange NASDAQ
  • Volume 230,940
  • Average Volume 240,804
  • Open $12.45
  • Previous Close $12.35
  • EPS -0.7
  • PE -16.99
  • Earnings Announcement 2024-11-07 10:59:00
  • Shares Outstanding $27,595,700

Company brief: CLEARPOINT NEURO, INC. (CLPT )

ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain stimulation electrodes and biopsy needles, and the infusion of pharmaceuticals and laser catheters into the brain; and ClearPoint Neuro Navigation System, an MRI suite. It has license and collaboration agreements with Boston Scientific Corporation, The Johns Hopkins University, Clinical Laserthermia Systems Americas Inc, Koninklijke Philips N.V., Blackrock Neurotech, and University of California and San Francisco. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

CLPT Corporation News

Income Statement